Sage Reports Positive Top-line Results Including Demonstration of 30-Day

... Read more

Sage Therapeutics Advances SAGE-217 into Placebo-Controlled Phase 2

... Read more

Sage Therapeutics Announces Brexanolone Achieves Primary Endpoints in

... Read more

Sage Therapeutics Reports Positive Top-line Results from Phase 2

... Read more

Salix Announces Statistically Significant Primary Endpoint Result for TARGET 3 Evaluating the Efficacy and Safety of Repeat Treatment

... Read more

Samco Gold Announces

... Read more

Santacruz Silver Announces

... Read more

Sarepta Therapeutics

... Read more

Sarepta Therapeutics Announces FDA Request For Dystrophin Data Prior To Making A

... Read more

Sarepta Therapeutics Announces Positive Results in Its Study Evaluating Gene

... Read more